Search

Your search keyword '"Schattenberg J."' showing total 176 results

Search Constraints

Start Over You searched for: Author "Schattenberg J." Remove constraint Author: "Schattenberg J."
176 results on '"Schattenberg J."'

Search Results

3. Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1–3 Infections

8. Nicht-alkoholische Fettlebererkrankung (NAFLD) in Deutschland: Baseline-Charakteristika von Patienten aus dem Deutschen NAFLD-Register

9. Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals

11. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD : an individual patient data meta-analysis

13. Additional file 1 of Impact of progressive familial intrahepatic cholestasis on caregivers: caregiver-reported outcomes from the multinational PICTURE study

14. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: An individual patient data meta-analysis

15. Risk factors for poorer health literacy in patients with liver cirrhosis

17. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis

18. Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025.

21. Applicability and safety of discontinuous ADVanced Organ Support (ADVOS) in the treatment of patients with acute-on-chronic liver failure (ACLF) outside of intensive care

24. Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1–3 Infections

25. T06.01.19 THE ECONOMIC COST AND HEALTH BURDEN OF NON-ALCOHOLIC STEATOHEPATITIS IN THE EU5 COUNTRIES

26. The economic cost and health burden of non-alcoholic steatohepatitis (NASH) in the EU5 countries

27. Obeticholic acid (OCA) improves experimental non-invasive markers of NASH and advanced fibrosis: results of a secondary analysis from the month-18 interim analysis of the REGENERATE study

28. The economic cost and health burden of non-alcoholic steatohepatitis in the EU5 countries

34. Persistenz von HCV Resistenz-assoziierten Substitutionen in NS3, NS5A und NS5B nach einem DAA Therapieversagen

35. Low frequencies of lifestyle interventions and liver-specific medications in a multicentric prospective real world NAFLD cohort: The fatty liver assessment in Germany (FLAG) study

38. Die Leberfunktion vor Lebertransplantation bestimmt das Überleben nach Lebertransplantation beim hepatozellulären Karzinom

40. Serological diagnosis of early HCC in NASH: A German multicenter study

44. Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals

49. Untersuchung von HCV Resistenzen in Verbindung mit dem Therapieansprechen bei Patienten mit einer chronischen Hepatitis C Genotyp 4 Infektion

Catalog

Books, media, physical & digital resources